
Ptat 75mg Tablet
Marketer
Divine Lifecare Pvt Ltd
Salt Composition
Clopidogrel (75mg)
Overview Ptat 75mg Tablet
CardioGuard 75mg tablets are antiplatelet agents, effectively reducing the risk of dangerous blood clot formation within blood vessels. This significantly lowers the probability of heart attack or stroke. A common medication for cardiovascular protection, CardioGuard 75mg is prescribed for individuals with elevated heart disease risk. This includes patients with peripheral artery disease (circulatory issues from narrowed arteries), recent stroke or myocardial infarction, cardiac arrhythmias, and those who have undergone specific cardiac interventions like stent placement. It's also used concurrently with other medications to manage heart attacks and certain types of angina. This medication can be administered with or without food, consistently at the same time daily. Continuous use is crucial, even during periods of wellness, as discontinuation increases the risk of cardiovascular events. The most prevalent side effect is increased bleeding, potentially manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual bleeding. Wound healing may be slower. While generally mild and self-limiting, persistent or concerning bleeding warrants immediate medical attention. This medication is contraindicated in individuals with active internal bleeding, such as gastrointestinal ulcers or intracranial hemorrhage. Prior to commencement, inform your physician of any history of bleeding disorders or recent major trauma or surgical procedures. Temporary cessation may be necessary before scheduled surgery or dental work.
Uses of Ptat 75mg Tablet
Avoiding heart attack and stroke
Major Benefits of Ptat 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 75mg Ptat tablet can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Ptat 75mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Ptat 75mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. The 75mg Ptat tablet can be consumed with or without food, though consistent timing is recommended.
How Ptat 75mg Tablet works:
Aggrenox 75mg tablets inhibit platelet aggregation, thus reducing the risk of dangerous blood clots and subsequently lowering the likelihood of cardiovascular events such as stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when combining Ptat 75mg Tablet and alcohol. Seek medical advice before doing so.
PregnancyCONSULT YOUR DOCTOR
The use of Ptat 75mg Tablet during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescription. Consult your doctor for guidance.
Breast feedingSAFE IF PRESCRIBED
The use of Ptat 75mg Tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Ptat 75mg Tablet.
KidneySAFE IF PRESCRIBED
Patients with kidney impairment may safely use Ptat 75mg tablets without requiring a dosage modification.
LiverSAFE IF PRESCRIBED
Ptat 75mg tablets pose no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Ptat 75mg Tablet :
Should you forget a Ptat 75mg Tablet dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing schedule. Never take a double dose.
Facts to Know About Ptat 75mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | ADP receptor antagonists (P2Y12 inhibitors) |
